期刊文献+

利用TCGA数据集分析AKT3在胃癌中的表达及临床意义 被引量:4

Analysis of Clinical Significance of AKT3 Expression in Gastric Cancer Utilizing TCGA Datasets
暂未订购
导出
摘要 目的研究AKT3在胃癌中的表达情况,预测并探讨AKT3参与肿瘤发生发展的可能机制及临床价值。方法从癌症基因组图谱(TCGA)数据库收集胃癌数据集,下载AKT3基因表达谱资料及临床信息资料。分析AKT3表达与胃癌临床病理学参数的相关性及对预后的影响。采用基因集富集分析(GSEA)方法预测AKT3的调控基因。结果 AKT3表达水平与肿瘤浸润深度(P=0.001)、TNM分期(P=0.049)、分化程度(P<0.001)相关,肿瘤恶性程度越高,AKT3表达越高。AKT3高表达患者总生存期明显短于低表达患者(P<0.001)。AKT3高表达样本富集了细胞黏附、骨架蛋白调控、紧密连接、TGF-β通路等基因集。结论在胃癌中,AKT3高表达是一种预后不良因素,可以作为预测患者转移发生、判断预后的有效生物标志物。 Objective To investigate the prognostic value of AKT3 expression in gastric cancer. Methods AKT3 expression data in The Cancer Genome Atlas (TCGA) datasets and its clinical information were downloaded. Statistically assessed was performed for relationship with clinicopatho- logical factors and prognosis. Gene set enrichment analysis (GSEA) was used to predict the gene sets modulated by AKT3. Results The expres- sion of AKT3 was associated with T stage(P = 0.001 ), TNM stage(P = 0.049) and differentiation(P 〈 0.001 ).High level of AKT3 expression indi- cates poor prognosis (P = 0.001 ). AKT3 could regulate gene sets involving cell adhesion molecule, cytoskeleton regulation, focal adhesion and TGF-β signaling pathway. Condusion AKT3 could be used as a potential prognostic marker and a therapeutic target in gastric cancer.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2016年第5期398-401,共4页 Journal of China Medical University
基金 国家自然科学基金(81302023) 国家科技重大新药创制(2013ZX09303002) 辽宁省科学技术计划(2014225013)
关键词 胃癌 癌症基因组图谱 AKT3 预后 gastric cancer cancer genome atlas AKT3 prognosis
  • 相关文献

参考文献12

  • 1Murugan AK, Dong J, Xie J, et al. Uncommon GNAQ, MMP8,AKT3, EGFR and PIK3R1 mutation in thyroid cancer [J]. Endoer Pathol,2011,22(2) :97-102.
  • 2Dummler B, Tschopp O, Hynx D, et al. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired [J]. Mol Cell Biol,2006,26(21) :8042-8051.
  • 3Kirkegaard T, Witton C J, Edwards J, et al. Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH [J ]. Histopathology, 2010,56(2) : 203-211.
  • 4Chin YR, Yoshida T, Marusyk A, et al. Targeting AKT3 signaling in triple - negative breast cancer [J]. Cancer Res, 2014, 74 (3) : 964-973.
  • 5Mo X,Cao Q,Liang H,et al. MicroRNA-610 suppresses the prolifer- ation of human glioblastoma cells by repressing CCND2 and AKT3 [J]. Mol Med Rep,2016,13(3) : 1961-1966.
  • 6Grottke A, Ewald F, Lange T, et al. Downregulation of AKT3 increas- es migration and metastasis in triple negative breast cancer cells by upregulating S100A4 [J]. PLoS One,2016,11 ( 1 ) : e0146370.
  • 7Teng Y, Zhang Y, Qu K, et al. MicroRNA-29B (mir-29b)regulates the warburg effect in ovariancancerby targeting AKT2 and AKT3 [J]. Oncotarget,2015,6(38) :40799-40814.
  • 8Zhang Y, Guo X, Xiong L, et al. Comprehensive analysis of micro RNA-regulated protein interaction network reveals the tumor sup- pressive role of microRNA- 149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway [J]. Mol Cancer,2014,13:253.
  • 9Chang S, Yao J, Suyama K, et al. N-cadherin regulates mammary tu- mor cell migration through AKT3 suppression [J ]. Oncogene, 2013, 32(4) : 422-430.
  • 10Paul-Samojedny M, Pudelko A, Suchanek-Raft R, et al. Knock- down of the AKT3 (PKB ~/) , PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro [ J ]. Tumour Biol, 2015,36 (5) : 3263-3277.

同被引文献14

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部